Patents Assigned to Signal Coordinating Therapy, Inc.
  • Methods and compositions for treating neoplasms
    Patent number: 7842314
    Abstract: The present invention comprises the periodic administration of a solution of neuraminidase to a patient with a neoplasm until the neoplasm has receded. The administration of the solution of neuraminidase can be administered by subcutaneous injection, intramuscular injection, intravenous injection, nasal administration, sublingual administration or transdermal administration. The present invention is effective in treating a wide variety of neoplasms.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: November 30, 2010
    Assignee: Signal Coordinating Therapy, Inc.
    Inventor: Ellis L. Kline